StonvexLoading…
StonvexStonvexStonvexCore line items from ADTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $286.09M | $1.08B | $792.25M | $512.81M |
Operating Income | $6.38M | $-15.60M | $-20.07M | $-17.29M |
Net Income | $-1.32M | $-45.66M | $-42.06M | $-31.80M |
EPS (Diluted) | $-0.01 | $-0.52 | $-0.50 | $-0.38 |
Total Assets | $1.19B | $1.20B | $1.21B | $1.22B |
Total Liabilities | $678.52M | $685.34M | $665.24M | $644.59M |
Cash & Equivalents | $88.27M | $95.70M | $93.68M | $106.27M |
Free Cash Flow OCF − CapEx | $5.17M | $98.03M | $67.46M | $63.26M |
Shares Outstanding | 80.55M | 79.93M | 79.83M | 79.78M |